Quinoline–sulfonamides as a multi-targeting neurotherapeutic for cognitive decline: <i>in vitro</i> , <i>in silico</i> studies and ADME evaluation of monoamine oxidases and cholinesterases inhibitorsSaquib Jalil, Jamshed Iqbal, Syed Mobashir Ali Abid et al.|RSC Advances|2024Cited by 20
Author response for "Quinoline–sulfonamides as a multi-targeting neurotherapeutic for cognitive decline: <i>in vitro</i>, <i>in silico</i> studies and ADME evaluation of monoamine oxidases and cholinesterases inhibitors"Saquib Jalil, Jamshed Iqbal, Abdul Hameed et al.|Unknown|2023Cited by 0
Author response for "Quinoline–sulfonamides as a multi-targeting neurotherapeutic for cognitive decline: <i>in vitro</i>, <i>in silico</i> studies and ADME evaluation of monoamine oxidases and cholinesterases inhibitors"Saquib Jalil, Jamshed Iqbal, Abdul Hameed et al.|Unknown|2024Cited by 0